Stories & Ideas

Featured blog

Pioneering Progress: The Lenmeldy™ Story

Orchard Therapeutics’ Lenmeldy™ is a first of its kind treatment for an ultra-...

Featured blog

From Surge to Sobriety: The State of Robotics Investment in 2024

Updating our annual report

Featured blog

New Digital Care Architecture: The "Four Ds of Digital Health" Meet the "Two As of Automation"

Building on the "Four Ds of Digital Health", two key automation advancements a...

Stories & Ideas

By: F-Prime Capital

Pioneering Progress: The Lenmeldy™ Story

By: Gaurav Tuli, Betsy Mulé

Travel Tech’s Startup Moment, Pt. 1: Modernizing the Hotel Stack

By: Carl Byers

New Digital Care Architecture: The “Four Ds of Digital Health” Meet ...

By: F-Prime Capital

F-Prime’s Summer Internship and Fellowship Program: Meet Our 2024 Interns and Fe...

By: F-Prime Capital

Pioneering Progress: The FARAPULSE™ Story

By: David Jegen

The State of Banking Report

Vestwell

Selling to financial advisors was the best way to distribute savings programs bo...

By: F-Prime Capital

Behind the Breakthrough: Q&A with Tammy Sun, Carrot Fertility

By: Sanjay Aggarwal

Video Interview: The State of Robotics report

By: David Jegen

Video Interview: Exploring the State of Fintech with NYSE Floor Talk

By: Abdul Abdirahman

Fintech Is Operating at Scale, With Huge Growth Potential

By: F-Prime Capital

Behind the Breakthrough: Q&A with Meena Mallipeddi, AmplifyMD

By: David Jegen, Sarah Lamont

How Fintech Is Disrupting Traditional Banks in 2024

By: David Jegen

In Fintech, 2023 Was the Year of “Regulation On, Risk Off”

By: David Jegen, Rocio Wu, John Lin, Abdul Abdirahman, Sarah Lamont

The 2024 State of Fintech Report

By: Carl Byers

The Four Ds of Digital Health

By: F-Prime Capital

Behind the Breakthrough: Q&A with Peptone, Kamil Tamiola

By: David Jegen

Building the Data Integration Layer for Wealth Management

By: John Lin, Abdul Abdirahman

Future Of Financial Advice – More Co-Pilot Than Autopilot

Structure Therapeutics

Biologics and peptides have revolutionized healthcare setting the stage for a ne...

By: Sanjay Aggarwal

A Venture Capitalist’s Perspective on Robotics

By: F-Prime Capital

Behind the Breakthrough: Q&A with Lyn Baranowski, Avalyn Pharma

By: Gaurav Tuli

Software Buying Has Changed Forever

By: F-Prime Capital

Behind the Breakthrough: Q&A with Stephen Smith, NOCD

By: John Lin

Tracking the Industry Rebound with the F-Prime Fintech Index

By: Betsy Mulé

Technologies Enabling the Future of Robotics

By: Betsy Mulé

Influencers Are a New Class of Travel Agents — But Lack the Right Tools

By: F-Prime Capital

Behind the Breakthrough: Q&A with Emanuele Ostuni, ARTBIO

By: Rocio Wu

The RTP Gold Rush: 10 FedNow Predictions

Beam Therapeutics

The team developed a DNA base editing technology that enabled more precise edits...

By: Alex Pasteur, Ph.D., Martin Taylor, Ph.D.

ARTBIO: Redefining cancer care through an entirely new class of alpha radioligan...

By: Sanjay Aggarwal

Key Takeaways from Robotics Invest 2023

By: Shervin Ghaemmaghami, John Lin

Albert Invent’s $7.5M Seed Round

By: Carl Byers

Why We Invested in Carrot Fertility: A global leader in fertility healthcare and...

By: Gaurav Tuli

Announcing the Travel Tech Titans: Celebrating the Game-Changing Innovators in T...

CHARM Therapeutics

Predicting the structure and nature of protein-ligand interactions could enable ...

By: Sanjay Aggarwal

A Bet on Vertical Robotics

By: Rocio Wu

There Are Gaps In The US Real-Time Payment System. Who Will Fill Them?

By: Sanjay Aggarwal

Robotics – Has the Time Finally Arrived for Venture Capital?

By: Rocio Wu

Toku Takes Flight: Revolutionizing Recurring Revenue Collection in LatAm

By: David Jegen

2022 Was The Calm Before The Storm For Tech Startups

By: David Jegen, John Lin, Rocio Wu, Abdul Abdirahman, Sarah Lamont

Assessing the State of Fintech

Denali Therapeutics

That needed to change. Through our affiliate FBRI, F-Prime has had a long-standi...

Equip

In 2019, Kristina Saffran and Dr. Erin Parks came to us with a slide deck and a ...

Prime Medicine

Using “search and replace” to address the fundamental causes of genetic disease.

By: David Jegen

Who Will Build the Bloomberg of Private Markets Data?

By: John Lin

Tracking the Disruptors With The F-Prime Fintech Index

By: Jay Farber

Introducing Ashby: The Data-Driven ATS

Peptone

Many human proteins are intrinsically disordered and play a critical role in key...

Orchard Therapeutics

But he only had a few pieces in hand. He and his co-founders had some of the mos...

Atalanta

Achieving broad distribution of RNAi therapeutics throughout the CNS has been a ...

By: John Lin, Abdul Abdirahman

Latchel: The Operating System for Property Management

By: John Lin, Betsy Mulé

Leading Mathison’s Series A to become the First All-In-One DEI Operating S...

By: Gaurav Tuli, Ben Gorman

Canary Technologies: Reinventing the Hotel Tech Stack

AviadoBio

Neurological disease remains the largest cause of disability and second leading ...

K36 Therapeutics

F-Prime has long been interested in precision medicine approaches that tackle th...

Flywire

Student was tasked with sending his international tuition payment to the univers...

By: Sanjay Aggarwal

The Next Wave of Autonomous Vehicles

By: Gaurav Tuli

Announcing our Investment in Deal Engine

RiskRecon

Co-founders Kelly White and Eric Blatte armed enterprises with modern cyber risk...

Quovo

Lowell Putnam joins David Jegen to reflect on Quovo’s biggest wins

Ultragenyx

When he approached us, he was looking for an investor who would understand rare ...

Project Beacon

Boston’s life science community needed efficient, affordable, accessible and equ...

Toast

Steve, Aman and Jon were at dinner when they realized the restaurant industry ne...